Form 4 for MRVI MARAVAI LIFESCIENCES HOLDINGS, INC.
Accepted 2022-01-27 00:00:00 ET · period of report 2022-01-25 · accession 0000899243-22-003415 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-27 | 2022-01-25 | MRVI | HULL CARL | CEO, Dir | A - Grant | — | +81.6K | 81.6K | New | — |
| D | 2022-01-27 | 2022-01-25 | MRVI | HULL CARL | CEO, Dir | A - Grant | $0.00 | +151.2K | 151.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-01-25 | A | A | 81,600 | — | 81,600 | D | — | — | (F1) Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting, subject to the Reporting Person's continued employment with the Issuer. The RSUs will vest in 1/3rd increments on each of February 15, 2023, February 15, 2024, and February 15, 2025, subject to the Reporting Person's continued employment with the Issuer. |
| 2 | Derivative | Employee Stock Options (Right to Buy) | 2022-01-25 | A | A | 151,200 | $0.00 | 151,200 | D | $26.32 · — to 2032-01-25 | 151,200 Class A Common Stock | (F2) Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. These options will vest 1/48th on March 15, 2022 and in equal 1/48th installments each month thereafter, subject to the Reporting Person's continued employment with the Issuer. |